Stalder, G., Suffiotti, M., Segot, A., Noto, A., Pantaleo, G., Spertini, O. and Obeid, M. (2023) “Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial”, Haematologica. Pavia, Italy, 108(1), pp. 234-239. doi: 10.3324/haematol.2022.281221.